Abstract:Functional group (FG) is one of the cornerstone concepts in organic chemistry and related areas. Wide spread of bioisosterism ideas in medicinal chemistry and beyond caused a striking rise in demand for novel FGs with defined impact on the developed compound properties. In this work, evaluation of 3,3-difluorooxetane unit (3,3-diFox) as a functional group for bioisosteric replacements is disclosed. Comprehensive experimental study (including multigram building block synthesis, quantification of steric and electronic properties, measurements of pKa, LogP, chemical stability, and biological evaluation of the 3,3-diFox-derived bioisostere of a drug candidate) revealed a prominent behavior of the 3,3-diFox fragment as a versatile substituent for early drug discovery programs.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to find new functional groups in drug discovery, especially to evaluate the potential of 3,3 - difluorooxetane (3,3 - diFox) unit as a bioisosteric substitute. Specifically, the research aims to reveal the remarkable behavior of 3,3 - diFox fragment as a multi - functional substituent in early drug discovery projects through comprehensive experimental studies, including the synthesis of multi - gram - scale building blocks, quantification of steric and electronic properties, measurement of pKa values and Log P, chemical stability, and biological evaluation. ### Research Background and Objectives 1. **Importance of Functional Groups**: Functional groups are a fundamental concept in organic chemistry and related fields, and play an important role in chemical transformation of compounds, specific ligand - target interactions, and improvement of drug physicochemical parameters. 2. **Application of Bioisosteres**: In recent years, the concept of bioisosteres has been widely used in medicinal chemistry, so the demand for new functional groups has increased dramatically. 3. **Potential of 3,3 - Difluorooxetane**: As a potential functional group, 3,3 - diFox can be used to replace other common functional groups (such as esters, amides, small cycloalkyl groups, etc.), thus achieving more refined regulation in drug design. ### Main Research Contents 1. **Multi - gram - scale Synthesis**: A multi - gram - scale synthesis method of 3,3 - diFox building blocks has been developed. 2. **Measurement of Physicochemical Properties**: - **Acidity and Alkalinity**: The pKa values of 3,3 - diFox derivatives were measured to evaluate their acid - base properties. - **Lipophilicity**: The effect of 3,3 - diFox on the lipophilicity of compounds was evaluated by Log P measurement. 3. **Structural and Electronic Properties**: - **X - ray Diffraction**: The structural characteristics of 3,3 - diFox fragment were studied by X - ray diffraction. - **Molecular Electrostatic Potential**: The molecular electrostatic potential of 3,3 - diFox was analyzed by DFT method to further understand its electronic properties. 4. **Chemical Stability**: The chemical stability of 3,3 - diFox under different reaction conditions was evaluated. 5. **Biological Evaluation**: 3,3 - diFox - substituted Tenovin - 6 analogues were prepared and their biological activities were evaluated, including the inhibitory activity against histone deacetylase SIRT1, lipophilicity, water solubility, cell permeability, P - glycoprotein affinity, and metabolic stability. ### Conclusions The research results show that 3,3 - diFox, as a multi - functional substituent, has significant potential in drug discovery. It can improve the physicochemical properties of compounds without significantly changing the biological activity, especially in improving hydrophilicity and reducing P - glycoprotein affinity. These characteristics make it a promising bioisosteric substitute and are expected to be widely used in future drug design.

3,3-Difluorooxetane – a Versatile Functional Group for Bioisosteric Replacements in Drug Discovery

3,3‐Difluorooxetane – A Versatile Functional Group for Bioisosteric Replacements in Drug Discovery

Machine learning- and structure-based discovery of a novel chemotype as FXR agonists for potential treatment of nonalcoholic fatty liver disease

Design, synthesis and biological evaluations of novel farnesoid X receptor (FXR) agonists

gem-Difluorinated Saturated O-Heterocycles – Promising Fragments for Bioisosteric Replacements in Drug Discovery

Physicochemical and Biological Evaluation of gem‐Difluorinated Saturated Oxygen Heterocycles as Bioisosteres for Drug Discovery

Direct Bioisostere Replacement Enabled by Metallaphotoredox Deoxydifluoromethylation

Oxetane as a part of modern medicinal chemistry toolbox: the case of 3,3-disubstituted building blocks

3D-QSAR and Molecular Dynamics Study of Isoxazole Derivatives to Identify the Structural Requirements for Farnesoid X Receptor (FXR) Agonists

Searching for "Greener" Bioequivalents of CF3 to Lower its Environmental Impact

Amino-oxetanes as amide isosteres by an alternative defluorosulfonylative coupling of sulfonyl fluorides

Streamlining SuFEx Inhibitor Development: A Unified Approach Using Orthogonal Sulfinate Protecting Groups

Defluorinative Functionalization Approach led by Difluoromethyl Anion Chemistry

Harnessing Oxetane and Azetidine Sulfonyl Fluorides for Opportunities in Drug Discovery

2‐ and 3‐Fluorocyclobutane Building Blocks for Organic and Medicinal Chemistry

Pyrazolidine-3,5-dione Derivatives As Potent Non-Steroidal Agonists of Farnesoid X Receptor: Virtual Screening, Synthesis, and Biological Evaluation.

Quantum Mechanical-Cluster Approach to Solve the Bioisosteric Replacement Problem in Drug Design

Organocatalytic Highly Enantioselective Monofluoroalkylation Of 3-Bromooxindoles: Construction Of Fluorinated 3,3 '-Disubstituted Oxindoles And Their Derivatives

Biomimetic Total Synthesis and the Biological Evaluation of Natural Product (-)-fargesone A As a Novel FXR Agonist